TNSN08475A1 - Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same - Google Patents
Stable pharmaceutical composition containing docetaxel and a method of manufacturing the sameInfo
- Publication number
- TNSN08475A1 TNSN08475A1 TNP2008000475A TNSN08475A TNSN08475A1 TN SN08475 A1 TNSN08475 A1 TN SN08475A1 TN P2008000475 A TNP2008000475 A TN P2008000475A TN SN08475 A TNSN08475 A TN SN08475A TN SN08475 A1 TNSN08475 A1 TN SN08475A1
- Authority
- TN
- Tunisia
- Prior art keywords
- pharmaceutical composition
- same
- containing docetaxel
- stable pharmaceutical
- manufacturing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/724—Cyclodextrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20060045715 | 2006-05-22 | ||
PCT/KR2007/002479 WO2007136219A1 (fr) | 2006-05-22 | 2007-05-22 | Composition pharmaceutique stable contenant du docétaxel et son procédé de préparation |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN08475A1 true TNSN08475A1 (en) | 2010-04-14 |
Family
ID=39090946
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2008000475A TNSN08475A1 (en) | 2006-05-22 | 2008-11-21 | Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same |
Country Status (25)
Country | Link |
---|---|
US (1) | US8791152B2 (fr) |
EP (1) | EP2019664B1 (fr) |
JP (1) | JP5369332B2 (fr) |
KR (2) | KR100917809B1 (fr) |
CN (1) | CN101484137B (fr) |
AU (1) | AU2007252371B2 (fr) |
BR (1) | BRPI0711893A2 (fr) |
CA (1) | CA2653124C (fr) |
CR (1) | CR10485A (fr) |
EA (1) | EA014071B1 (fr) |
EC (1) | ECSP088951A (fr) |
ES (1) | ES2560641T3 (fr) |
GE (1) | GEP20115200B (fr) |
GT (1) | GT200800257A (fr) |
HK (1) | HK1128874A1 (fr) |
IL (1) | IL195459A (fr) |
MA (1) | MA30501B1 (fr) |
MX (1) | MX2008014948A (fr) |
MY (1) | MY149627A (fr) |
NO (1) | NO20084932L (fr) |
NZ (1) | NZ573202A (fr) |
SV (1) | SV2008003106A (fr) |
TN (1) | TNSN08475A1 (fr) |
WO (1) | WO2007136219A1 (fr) |
ZA (1) | ZA200809998B (fr) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2377318T3 (es) | 2002-09-06 | 2012-03-26 | Cerulean Pharma Inc. | Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos |
US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
CN102014918A (zh) * | 2007-04-20 | 2011-04-13 | 太阳医药工业有限公司 | 由微量沉淀产生的药学组合物 |
KR101502533B1 (ko) * | 2007-11-22 | 2015-03-13 | 에스케이케미칼주식회사 | 우수한 안정성을 갖는 택산 유도체 함유 주사제용동결건조 조성물 및 이의 제조방법 |
AU2008346121B2 (en) * | 2007-12-24 | 2013-10-10 | Sun Pharma Advanced Research Company Limited | Nanodispersion |
KR101053780B1 (ko) * | 2008-02-29 | 2011-08-02 | 동아제약주식회사 | 도세탁셀을 함유하는 단일액상의 안정한 약제학적 조성물 |
EP2442805A4 (fr) | 2009-06-19 | 2012-11-21 | Sun Pharma Advanced Res Co Ltd | Nanodispersion d'un médicament et son procédé de préparation |
EP2477985B1 (fr) * | 2009-09-15 | 2018-11-07 | BlueLink Pharmaceuticals, Inc. | Crlx101 pour son utilisation dans le traitement du cancer |
EA201200617A1 (ru) | 2009-11-23 | 2012-11-30 | Серулин Фарма Инк. | Полимеры на основе циклодекстрина для доставки лекарственных средств |
JP5824511B2 (ja) | 2010-05-03 | 2015-11-25 | テイコク ファーマ ユーエスエー インコーポレーテッド | 非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法 |
KR20120130740A (ko) * | 2011-05-23 | 2012-12-03 | 에스케이케미칼주식회사 | 도세탁셀을 함유하는 액상 주사용 조성물 |
WO2012161520A2 (fr) * | 2011-05-23 | 2012-11-29 | 에스케이케미칼 주식회사 | Composition liquide injectable contenant du docétaxel |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
US20140094432A1 (en) | 2012-10-02 | 2014-04-03 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
EP2777691A1 (fr) * | 2013-03-14 | 2014-09-17 | Pharmachemie B.V. | Taxoïde - purification des excipients liquides |
KR20140147336A (ko) * | 2013-06-19 | 2014-12-30 | 에스케이케미칼주식회사 | 도세탁셀을 함유하는 액상 주사용 조성물 |
EP3154535A4 (fr) * | 2014-06-12 | 2018-02-14 | University of Notre Dame du Lac | Composition et méthode de traitement de maladies neurologiques et de lésions cérébrales |
WO2016149162A1 (fr) | 2015-03-16 | 2016-09-22 | Meridian Lab | Compositions pharmaceutique contenant du des complexes de taxane-cyclodextrine, procédé de production et procédés d'utilisation |
CA3002113C (fr) * | 2015-10-20 | 2024-05-28 | B. Braun Melsungen Ag | Composition aqueuse comprenant du dantrolene |
US20190224332A1 (en) * | 2016-09-07 | 2019-07-25 | Cadila Healthcare Limited | Sterile injectable compositions comprising drug micelles |
CN113559277B (zh) * | 2018-01-11 | 2023-11-17 | 比卡生物科技(广州)有限公司 | 一种注射用卡巴他赛组合物及其制备方法 |
CN113456586B (zh) * | 2018-07-25 | 2022-06-10 | 比卡生物科技(广州)有限公司 | 一种注射用多西他赛组合物及其制备方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2548992A (en) * | 1991-08-13 | 1993-03-16 | Temple University - Of The Commonwealth System Of Higher Education | Modulation of blood pressure and inhibition of platelet activation with kininogen fragment |
US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
HUT73844A (en) * | 1994-11-11 | 1996-09-30 | Chinoin Gyogyszer Es Vegyeszet | New taxol complexes and pharmaceutical compositions containing them |
US6458373B1 (en) | 1997-01-07 | 2002-10-01 | Sonus Pharmaceuticals, Inc. | Emulsion vehicle for poorly soluble drugs |
GB9711643D0 (en) * | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
HUP9701945A3 (en) * | 1997-11-10 | 2000-04-28 | Hexal Ag | Pharmaceutical composition for injection containing cyclodextrin and taxoids |
US6133473A (en) * | 1998-06-25 | 2000-10-17 | Rohm And Haas Company | Synthesis of carbamate compounds |
US6294192B1 (en) | 1999-02-26 | 2001-09-25 | Lipocine, Inc. | Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents |
KR100310839B1 (ko) | 1999-03-23 | 2001-10-12 | 정기련 | 안정성이 개선된 파크리탁셀 가용화 주사제 조성물 |
KR20070058028A (ko) | 1999-05-24 | 2007-06-07 | 소너스파머슈티칼즈인코포레이티드 | 난용성 약물용 에멀젼 부형제 |
US6395300B1 (en) | 1999-05-27 | 2002-05-28 | Acusphere, Inc. | Porous drug matrices and methods of manufacture thereof |
KR100883477B1 (ko) | 1999-05-27 | 2009-02-16 | 아쿠스피어 인코포레이티드. | 다공성 약물 매트릭스의 약제 조성물 |
US20030157161A1 (en) * | 2001-05-01 | 2003-08-21 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents |
US20040253315A1 (en) * | 2001-07-13 | 2004-12-16 | Yasuaki Ogawa | Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof |
KR20030041577A (ko) * | 2001-11-20 | 2003-05-27 | 디디에스텍주식회사 | 난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물 |
JP2003342168A (ja) * | 2002-05-24 | 2003-12-03 | Nano Career Kk | 注射用薬物含有ポリマーミセル製剤の製造方法 |
CN100518831C (zh) * | 2002-08-15 | 2009-07-29 | 刘云清 | 固体纳米药物及其制备方法 |
CN1502332A (zh) * | 2002-11-25 | 2004-06-09 | 刘云清 | 抗癌药紫杉醇自乳化固体纳米粒——注射用紫杉醇的制备方法 |
US20040127551A1 (en) | 2002-12-27 | 2004-07-01 | Kai Zhang | Taxane-based compositions and methods of use |
JP2005075783A (ja) * | 2003-09-01 | 2005-03-24 | Otsuka Pharmaceut Factory Inc | 難溶性化合物の可溶化または分散化用組成物 |
WO2006098241A1 (fr) * | 2005-03-14 | 2006-09-21 | Otsuka Pharmaceutical Factory, Inc. | Composition pharmaceutique contenant un médicament à peine soluble dans l'eau |
-
2007
- 2007-05-21 KR KR1020070049340A patent/KR100917809B1/ko active IP Right Grant
- 2007-05-22 WO PCT/KR2007/002479 patent/WO2007136219A1/fr active Application Filing
- 2007-05-22 ES ES07746627.4T patent/ES2560641T3/es active Active
- 2007-05-22 JP JP2009511943A patent/JP5369332B2/ja not_active Expired - Fee Related
- 2007-05-22 CA CA2653124A patent/CA2653124C/fr not_active Expired - Fee Related
- 2007-05-22 NZ NZ573202A patent/NZ573202A/en not_active IP Right Cessation
- 2007-05-22 AU AU2007252371A patent/AU2007252371B2/en not_active Ceased
- 2007-05-22 EA EA200870559A patent/EA014071B1/ru not_active IP Right Cessation
- 2007-05-22 MX MX2008014948A patent/MX2008014948A/es active IP Right Grant
- 2007-05-22 GE GEAP200711018A patent/GEP20115200B/en unknown
- 2007-05-22 BR BRPI0711893-7A patent/BRPI0711893A2/pt not_active IP Right Cessation
- 2007-05-22 MY MYPI20084753A patent/MY149627A/en unknown
- 2007-05-22 EP EP07746627.4A patent/EP2019664B1/fr active Active
- 2007-05-22 CN CN200780024837.8A patent/CN101484137B/zh not_active Expired - Fee Related
- 2007-05-22 US US12/301,700 patent/US8791152B2/en not_active Expired - Fee Related
-
2008
- 2008-11-21 TN TNP2008000475A patent/TNSN08475A1/en unknown
- 2008-11-21 GT GT200800257A patent/GT200800257A/es unknown
- 2008-11-23 IL IL195459A patent/IL195459A/en not_active IP Right Cessation
- 2008-11-24 SV SV2008003106A patent/SV2008003106A/es unknown
- 2008-11-25 ZA ZA200809998A patent/ZA200809998B/xx unknown
- 2008-11-25 NO NO20084932A patent/NO20084932L/no not_active Application Discontinuation
- 2008-12-05 MA MA31456A patent/MA30501B1/fr unknown
- 2008-12-09 CR CR10485A patent/CR10485A/es unknown
- 2008-12-11 EC EC2008008951A patent/ECSP088951A/es unknown
-
2009
- 2009-08-03 HK HK09107096.9A patent/HK1128874A1/zh not_active IP Right Cessation
- 2009-08-26 KR KR1020090079337A patent/KR100983376B1/ko active IP Right Grant
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY149627A (en) | Stable pharmaceutical composition containing docetaxel and a method of manufacturing the same | |
WO2009066955A3 (fr) | Composition pharmaceutique lyophilisée à stabilité améliorée contenant des dérivés de taxane, et procédé de préparation correspondant | |
WO2007084460A3 (fr) | Compositions pharmaceutiques a stabilite amelioree | |
Ulbricht et al. | On the biodegradability of polyethylene glycol, polypeptoids and poly (2-oxazoline) s | |
EA200870219A1 (ru) | Стабилизированные сукцинатом витамина е фармацевтические композиции, способы их получения и применения | |
CY1109425T1 (el) | Φαρμακευτικες συνθεσεις για τη χορηγηση με ελεγχομενη αποδεσμευση βιολογικα δραστικων ενωσεων | |
PE20060003A1 (es) | Formulacion farmaceutica polimerica para moldear por inyeccion | |
BRPI0615292A8 (pt) | composições e métodos para preparação de fármacos de má solubilidade em água com estabilidade aumentada | |
ES2556585T3 (es) | Composiciones que comprenden sulfato de salbutamol | |
EA200900572A1 (ru) | Мицеллярные наночастицы с химическими субстанциями | |
JO2932B1 (en) | Lyspro insulin compounds linked to PEG | |
WO2011015634A3 (fr) | Formulations à libération contrôlée de mutéines de la lipocaline | |
WO2009066956A3 (fr) | Composition pharmaceutique lyophilisée présentant un temps de reconstitution amélioré et contenant des dérivés de taxane et son procédé de fabrication | |
EP2679244A3 (fr) | Formulations stabilisant et inhibant la précipitation de compositions immunogènes | |
WO2010125475A3 (fr) | Formulations à libération prolongée | |
MXPA06012583A (es) | Nanoparticulas pegiladas. | |
TW200744677A (en) | Compositions and methods for preparation of poorly water soluble drugs with increased stability | |
WO2007056205A3 (fr) | Esters de carboxyalkylcellulose pour administration d'agents pharmaceutiquement actifs peu solubles | |
AR071375A1 (es) | Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto | |
MX347056B (es) | Composiciones farmaceuticas. | |
EA201170512A1 (ru) | Композиция для перорального введения | |
WO2010045281A3 (fr) | Formulations aqueuses stables de medicaments insolubles ou peu solubles dans l'eau | |
EA201101286A1 (ru) | Композиции биодоступных капсул некристаллического соединения альфа-(n-сульфонамидо)ацетамина | |
WO2011056702A3 (fr) | Compositions de revêtement à dissolution/désintégration rapide | |
UA93249C2 (uk) | Стабільна фармацевтична композиція, яка містить доцетаксел, і спосіб виготовлення такої композиції |